MENU
+Compare
SSKN
Stock ticker: NASDAQ
AS OF
Aug 15 closing price
Price
$1.82
Change
+$0.01 (+0.55%)
Capitalization
7.59M

SSKN Strata Skin Sciences Forecast, Technical & Fundamental Analysis

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders... Show more

SSKN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SSKN with price predictions
Aug 15, 2025

Momentum Indicator for SSKN turns negative, indicating new downward trend

SSKN saw its Momentum Indicator move below the 0 level on July 16, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 120 similar instances where the indicator turned negative. In of the 120 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SSKN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SSKN entered a downward trend on August 15, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SSKN's RSI Oscillator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for SSKN just turned positive on August 15, 2025. Looking at past instances where SSKN's MACD turned positive, the stock continued to rise in of 57 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SSKN advanced for three days, in of 223 cases, the price rose further within the following month. The odds of a continued upward trend are .

SSKN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.829) is normal, around the industry mean (59.654). P/E Ratio (0.000) is within average values for comparable stocks, (38.618). SSKN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.709). SSKN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (0.214) is also within normal values, averaging (92.479).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SSKN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SSKN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
SSKN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a manufacturer of dermatology treatment products

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
5 Walnut Grove Drive
Phone
+1 215 619-3200
Employees
99
Web
https://www.strataskinsciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RXRX5.770.13
+2.30%
Recursion Pharmaceuticals
UHT38.430.03
+0.08%
Universal Health Realty Income Trust
LNT64.62-0.10
-0.15%
Alliant Energy Corp
MGNX1.58-0.04
-2.47%
MacroGenics
SHFS2.60-0.56
-17.59%
SHF Holdings Inc

SSKN and Stocks

Correlation & Price change

A.I.dvisor tells us that SSKN and VERO have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SSKN and VERO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SSKN
1D Price
Change %
SSKN100%
+0.55%
VERO - SSKN
30%
Poorly correlated
-5.31%
DCTH - SSKN
26%
Poorly correlated
-1.05%
IVF - SSKN
25%
Poorly correlated
-10.29%
ANIK - SSKN
25%
Poorly correlated
+2.20%
ARAY - SSKN
22%
Poorly correlated
-4.11%
More

Groups containing SSKN

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SSKN
1D Price
Change %
SSKN100%
+0.55%
Health Services
category (440 stocks)
4%
Poorly correlated
-0.02%
Medical/Nursing Services
category (226 stocks)
4%
Poorly correlated
-0.79%